1 Product identity
Ingredient risk
1 ingredient to use with caution
Pain-Rx
BrandHi-Tech Pharmaceuticals→Botanical Tablet or Pill 20 ingredients 1 caution DSLD #10286Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-06-25
2 Ingredients (20)
IngredientGroupSafety
Proprietary blend with Explotab(TM) TechnologyProprietary Blend (Combination)—
Paulownia tomentosa extractEmpresstree—
Chiococca alba extractDavid's Milkberry—
Mimosa pudica extractSensitive Plant—
Phellodendron amurense bark extractPhellodendron —
Lactuca virosa extractLactucarium—
White Willow 90% extractWhite Willow—
NaringenNaringenin—
6-7 Dihydroxybergamottin——
Yerba Mate extractMate—
Microcrystalline CelluloseCellulose—
DextroseGlucose—
Stearic AcidStearic Acid—
Carnauba WaxCarnauba wax—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Valerian — Conditionally Safe
⚠ Drowsiness
⚠ Additive with sedatives/alcohol
Boswellia — Generally Safe
⚠ GI discomfort
⚠ May enhance anticoagulants
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID10286
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-06-25
6 More from Hi-Tech Pharmaceuticals
View Hi-Tech Pharmaceuticals Safety Scorecard → 50 products
Allergy-RxAnavarAnavar-PCr Tropical Punch FlavorAttention LinkBulasteroneCaralluma Fimbriata 20:1 extract 500 mg7 Cite this page
Vancouver
Pkhakadze G. Pain-Rx — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/pain-rx-10286/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG